Have questions? Contact Us
2025 CDC Vaccine & Immunization Changes
Medical professionals can easily view what’s new for the 2025 Vaccine & Immunization recommendations. The updates for the 2025 Immunization Schedule for Child & Adolescent as well as the 2025 Adult Immunization Schedule have been clearly presented on this CDC page.
There are a few significant changes to the immunization recommendations to review, just to name a few; the MenB vaccine, Bexsero has a new dosing schedule, the HepB vaccine Heplisav-B now may be considered for pregnant women. For pneumococcal immunization, PCV vaccines, Capvaxive PCV21 & Prevnar PCV20 have a new lowered recommended age for use in adults. RSV vaccines also have a change to the recommended age of 75 for adults. These important vaccination updates are presented in a layout that’s a quick read on what healthcare providers want to know.
Providing immunization services can be made financially feasible through PracticeWell’s The Physician Buying Group vaccine purchasing contracts. From infant vaccines to adult vaccines, PracticeWell members may access preferential pricing programs for most vaccine manufacturers with U.S. licensed vaccines. Merck, Sanofi, Pfizer, GSK, Moderna, Dynavax, AstraZeneca, Bavarian Nordic, CSL Seqirus…...Don’t hesitate to vaccinate and don’t delay, join PracticeWell today!